NO991405L - Belagt partikkelformulering - Google Patents

Belagt partikkelformulering

Info

Publication number
NO991405L
NO991405L NO991405A NO991405A NO991405L NO 991405 L NO991405 L NO 991405L NO 991405 A NO991405 A NO 991405A NO 991405 A NO991405 A NO 991405A NO 991405 L NO991405 L NO 991405L
Authority
NO
Norway
Prior art keywords
coated particle
particle formulation
formulation
preparing
pharmaceutically acceptable
Prior art date
Application number
NO991405A
Other languages
English (en)
Other versions
NO991405D0 (no
Inventor
Tommy Clifford Morris
Hans Joerg Lange
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO991405D0 publication Critical patent/NO991405D0/no
Publication of NO991405L publication Critical patent/NO991405L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Oppfinnelsen tilveiebringe! en farmasøytisk akseptabel fast oral olanzapinformulering og en fremgangsmåte for fremstilling av slik formulering.
NO991405A 1996-09-24 1999-03-23 Belagt partikkelformulering NO991405L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2663396P 1996-09-24 1996-09-24
PCT/US1997/016547 WO1998013027A1 (en) 1996-09-24 1997-09-18 Coated particle formulation

Publications (2)

Publication Number Publication Date
NO991405D0 NO991405D0 (no) 1999-03-23
NO991405L true NO991405L (no) 1999-03-23

Family

ID=21832952

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991405A NO991405L (no) 1996-09-24 1999-03-23 Belagt partikkelformulering

Country Status (21)

Country Link
US (1) US20010020032A1 (no)
EP (1) EP0830858A1 (no)
JP (1) JP2001501207A (no)
KR (1) KR20000048540A (no)
CN (1) CN1230883A (no)
AR (1) AR009802A1 (no)
AU (1) AU719788B2 (no)
BR (1) BR9713215A (no)
CA (1) CA2266448A1 (no)
CO (1) CO4910139A1 (no)
CZ (1) CZ98899A3 (no)
EA (1) EA001610B1 (no)
HU (1) HUP9904065A3 (no)
ID (1) ID21762A (no)
IL (1) IL128845A0 (no)
NO (1) NO991405L (no)
PE (1) PE27899A1 (no)
PL (1) PL332503A1 (no)
TR (1) TR199900651T2 (no)
WO (1) WO1998013027A1 (no)
ZA (1) ZA978517B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9922271D0 (en) * 1999-09-21 1999-11-17 Zeneca Ltd Formulation
TWI275394B (en) * 2000-01-26 2007-03-11 Asahi Chemical Corp Mizoribin tablet improved with color tone change
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SI21303A (sl) * 2002-10-18 2004-04-30 Krka, Tovarna Zdravil, D.D.,, Novo Mesto Farmacevtska formulacija olanzapina
US20070218139A1 (en) 2002-12-20 2007-09-20 Smith Thomas J High Pressure Compaction For Pharmaceutical Formulations
SI21402A (sl) 2003-02-12 2004-08-31 LEK farmacevtska dru�ba d.d. Obloženi delci in farmacevtske oblike
JP4808612B2 (ja) * 2003-04-25 2011-11-02 田辺三菱製薬株式会社 アルキレンジオキシベンゼン誘導体を含む経口投与用組成物
WO2005009407A2 (en) * 2003-07-29 2005-02-03 Ranbaxy Laboratories Limited Oral pharmaceutical formulations of olanzapine
ES2303462B1 (es) 2004-09-06 2009-06-05 Shasun Chemicals And Drugs Limited Nuevo procedimiento para la preparacion de una forma polimorfica i de olanzapina farmaceuticamente pura.
CZ297214B6 (cs) * 2005-02-02 2006-10-11 Zentiva, A. S. Lécivý prípravek obsahující jako úcinnou slozku olanzapin a zpusob jeho výroby
WO2007049304A2 (en) * 2005-10-27 2007-05-03 Jubilant Organosys Limited Stable coated pharmaceutical formulation of olanzapine and process for preparing the same
ES2279715B1 (es) * 2005-12-26 2008-06-01 Laboratorios Lesvi, S.L. Formulacion oral de olanzapina.
WO2007134845A2 (en) * 2006-05-18 2007-11-29 Synthon B.V. Olanzapine pharmaceutical composition
ATE465720T1 (de) * 2006-07-05 2010-05-15 Bilim Ilac Sanayii Ve Ticaret Stabile olanzapin-formulierung mit antioxidantien
CL2007002807A1 (es) * 2006-09-29 2008-04-11 Synthon Bv Composicion farmaceutica en estado solido que comprende olanzapina o una sal farmaceuticamente aceptable de la misma y lactosa anhidra; tableta farmaceutica oral; procedimiento de preparacion de dicha tableta, util en el tratamiento de la esquizofren
SI2563763T1 (sl) * 2010-04-30 2015-03-31 Bristol-Myers Squibb Company Farmacevtski sestavki, ki obsegajo N-(4-(2-amino-3-kloropiridin-4-iloksi)-3-fluorofenil)-4-etoksi-L-(4- fluorofenil)-2-okso-1,2-dihidropiridin-3-karboksamid
WO2012153347A2 (en) 2011-05-04 2012-11-15 Zentiva K.S. Oral pharmaceutical composition of olanzapine form 1
EP2976062B1 (en) 2013-03-21 2021-11-03 Eupraxia Pharmaceuticals USA LLC Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
CN108289857A (zh) 2015-10-27 2018-07-17 优普顺药物公司 局部麻醉药的持续释放制剂
CN107007559B (zh) * 2017-04-21 2020-05-15 浙江京新药业股份有限公司 一种稳定的口服药物组合物及其制备方法
KR20200110648A (ko) 2017-12-05 2020-09-24 선오비온 파마슈티컬스 인코포레이티드 비라세믹 혼합물 및 이의 용도
KR20200110317A (ko) 2017-12-05 2020-09-23 선오비온 파마슈티컬스 인코포레이티드 결정형 및 이의 제조 방법
AU2020286441A1 (en) 2019-06-04 2022-01-06 Sunovion Pharmaceuticals Inc. Modified release formulations and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
ZA922777B (en) * 1991-04-29 1993-10-15 Lilly Co Eli Pharmaceutical formulation containing dirithromycin
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
SE9302395D0 (sv) * 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
IL117612A0 (en) * 1995-03-24 1996-07-23 Lilly Co Eli Granule formulation for olanzapine
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina

Also Published As

Publication number Publication date
AU4423097A (en) 1998-04-17
IL128845A0 (en) 2000-01-31
WO1998013027A1 (en) 1998-04-02
HUP9904065A2 (hu) 2000-04-28
ZA978517B (en) 1999-03-23
BR9713215A (pt) 2000-04-04
JP2001501207A (ja) 2001-01-30
AR009802A1 (es) 2000-05-03
EP0830858A1 (en) 1998-03-25
PE27899A1 (es) 1999-03-12
PL332503A1 (en) 1999-09-13
TR199900651T2 (xx) 1999-07-21
EA001610B1 (ru) 2001-06-25
EA199900331A1 (ru) 2000-04-24
HUP9904065A3 (en) 2001-10-29
US20010020032A1 (en) 2001-09-06
NO991405D0 (no) 1999-03-23
ID21762A (id) 1999-07-22
CA2266448A1 (en) 1998-04-02
KR20000048540A (ko) 2000-07-25
CZ98899A3 (cs) 1999-12-15
CN1230883A (zh) 1999-10-06
CO4910139A1 (es) 2000-04-24
AU719788B2 (en) 2000-05-18

Similar Documents

Publication Publication Date Title
NO991405L (no) Belagt partikkelformulering
TR199701018T1 (xx) Oral 2-metil-tieno-benzodiazepin form�lasyonu.
HRP980163B1 (en) Pharmaceutical composition for the oral administration of an n-piperidinopyrazole -3-carboxamide derivative, its salts and their solvates
MY125467A (en) Olanzapine dihydrate d
AU6853598A (en) Aligner, exposure method using the aligner, and method of manufacture of circuitdevice
AU1053199A (en) Exposure apparatus and method of manufacturing the same, and exposure method
YU15299A (sh) Farmaceutski sastavi
NO910687D0 (no) Fremgangsmaate for fremstilling av et stabilt soetningsmiddel-utleveringssystem og tyggegummi.
IL122485A0 (en) Arylsulfonylaminobenzene derivatives and pharmaceutical compositions containg the same
HUP9702509A3 (en) Derivatives of fused heterocycles substituted on the aminogroup, process for producing them, their use and pharmaceutical compositions thereof
HUP9901685A3 (en) Colchicine derivatives, the use thereof and formulations containing them
HUP0002300A3 (en) Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use
HK1036974A1 (en) Indole derivatives and medicinal compositions containing the same.
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
ES2172182T3 (es) Composiciones farmaceuticas que comprenden cefuroxima axetil.
AU1671197A (en) Vaccine-containing emulsion and vaccine-containing powder for oral administration and process for producing the same
AU8040991A (en) Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof
ZA972708B (en) Pharmaceutical compositions and methods for the manufacture thereof.
AU697041B2 (en) Mannich base derivatives, and the production and uses thereof
IL118002A (en) Insecticide formulations and process for the manufacture thereof
GB2325229B (en) 2,3-Disubstituted cyclopentanone derivatives, process for producing the same, and medicinal use thereof
JO1909B1 (en) Composition of 2-methylthenio-benzodiazepine oral
AU3241401A (en) Testing xenografts and sources thereof for retrovirus
IL117302A (en) Cryptophycin derivatives, methods for the production thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application